WWW.EXFILE.COM, INC. -- 14991 -- BOSTON SCIENTIFIC CORP. -- FORM 8-K

Boston Scientific (BSX)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

8-K

8-K (Oct 26, 2017)8-K (Oct 11, 2017)8-K (Aug 7, 2017)8-K (Jul 27, 2017)8-K (May 11, 2017)8-K (Apr 27, 2017)8-K (Apr 18, 2017)8-K (Mar 30, 2017)8-K (Feb 23, 2017)8-K (Feb 10, 2017)8-K (Feb 2, 2017)8-K (Jan 20, 2017)8-K (Nov 22, 2016)8-K (Oct 26, 2016)8-K (Sep 27, 2016)8-K (Jul 28, 2016)8-K (Jul 20, 2016)8-K (Jul 13, 2016)8-K (Jun 9, 2016)8-K (May 5, 2016)8-K (Apr 27, 2016)8-K (Feb 25, 2016)8-K (Feb 4, 2016)8-K (Oct 28, 2015)8-K (Oct 5, 2015)8-K (Aug 4, 2015)8-K (Jul 23, 2015)8-K (Jul 15, 2015)8-K (May 12, 2015)8-K (May 8, 2015)8-K (May 6, 2015)8-K (May 1, 2015)8-K (Apr 28, 2015)8-K (Apr 14, 2015)8-K (Mar 3, 2015)8-K (Mar 2, 2015)8-K (Feb 17, 2015)8-K (Feb 4, 2015)8-K (Jan 6, 2015)8-K (Oct 30, 2014)8-K (Oct 22, 2014)8-K (Oct 3, 2014)8-K (Sep 24, 2014)8-K (Jul 24, 2014)8-K (May 15, 2014)8-K (May 8, 2014)8-K (Apr 29, 2014)8-K (Mar 3, 2014)8-K (Feb 4, 2014)8-K (Dec 16, 2013)8-K (Oct 25, 2013)8-K (Oct 24, 2013)8-K (Oct 23, 2013)8-K (Aug 13, 2013)8-K (Aug 9, 2013)8-K (Jul 25, 2013)8-K (Jul 1, 2013)8-K (Jun 28, 2013)8-K (May 29, 2013)8-K (May 9, 2013)8-K (Apr 25, 2013)8-K (Mar 6, 2013)8-K (Jan 29, 2013)8-K (Nov 19, 2012)8-K (Nov 1, 2012)8-K (Oct 18, 2012)8-K (Oct 9, 2012)8-K (Jul 26, 2012)8-K (Jul 6, 2012)8-K (May 14, 2012)8-K (Apr 19, 2012)8-K (Mar 8, 2012)8-K (Mar 2, 2012)8-K (Feb 2, 2012)8-K (Dec 16, 2011)8-K (Dec 7, 2011)8-K (Nov 23, 2011)8-K (Oct 28, 2011)8-K (Oct 20, 2011)8-K (Sep 27, 2011)8-K (Sep 19, 2011)8-K (Sep 12, 2011)8-K (Aug 1, 2011)8-K (Jul 28, 2011)8-K (May 13, 2011)8-K (May 10, 2011)8-K (Apr 20, 2011)8-K (Mar 4, 2011)8-K (Feb 1, 2011)8-K (Jan 25, 2011)8-K (Jan 19, 2011)8-K (Jan 13, 2011)8-K (Jan 10, 2011)8-K (Jan 3, 2011)8-K (Dec 21, 2010)8-K (Dec 20, 2010)8-K (Nov 19, 2010)8-K (Nov 1, 2010)8-K (Oct 28, 2010)8-K (Oct 19, 2010)8-K (Sep 20, 2010)8-K (Aug 11, 2010)8-K (Jul 20, 2010)8-K (Jun 23, 2010)8-K (May 21, 2010)8-K (May 17, 2010)8-K (Apr 27, 2010)8-K (Apr 26, 2010)8-K (Apr 15, 2010)8-K (Mar 29, 2010)8-K (Mar 15, 2010)8-K (Mar 1, 2010)8-K (Feb 10, 2010)8-K (Feb 1, 2010)8-K (Dec 23, 2009)8-K (Dec 21, 2009)8-K (Dec 14, 2009)8-K (Dec 11, 2009)8-K (Dec 10, 2009)8-K (Nov 6, 2009)8-K (Nov 5, 2009)8-K (Nov 2, 2009)8-K (Oct 20, 2009)8-K (Oct 2, 2009)8-K (Jul 31, 2009)8-K (Jul 21, 2009)8-K (Jun 25, 2009)8-K (May 27, 2009)8-K (Apr 21, 2009)8-K (Apr 15, 2009)8-K (Mar 20, 2009)8-K (Mar 13, 2009)8-K (Mar 5, 2009)8-K (Mar 2, 2009)8-K (Feb 26, 2009)8-K (Jan 29, 2009)8-K (Jan 20, 2009)8-K (Dec 22, 2008)8-K (Oct 31, 2008)8-K (Oct 21, 2008)8-K (Oct 14, 2008)8-K (Oct 8, 2008)8-K (Aug 1, 2008)8-K (Jul 21, 2008)8-K (Jun 19, 2008)8-K (Jun 3, 2008)8-K (May 28, 2008)8-K (May 20, 2008)8-K (May 8, 2008)8-K (Apr 21, 2008)8-K (Feb 29, 2008)8-K (Feb 15, 2008)8-K (Feb 5, 2008)8-K (Jan 25, 2008)8-K (Jan 10, 2008)8-K (Jan 9, 2008)8-K (Dec 21, 2007)8-K (Nov 19, 2007)8-K (Nov 13, 2007)8-K (Nov 6, 2007)8-K (Nov 2, 2007)8-K (Oct 19, 2007)8-K (Sep 6, 2007)8-K (Aug 23, 2007)8-K (Aug 15, 2007)8-K (Aug 3, 2007)8-K (Jul 20, 2007)8-K (Jul 16, 2007)8-K (May 11, 2007)8-K (May 7, 2007)8-K (May 1, 2007)8-K (Apr 23, 2007)8-K (Mar 12, 2007)8-K (Mar 6, 2007)8-K (Feb 26, 2007)8-K (Feb 1, 2007)8-K (Jan 10, 2007)8-K (Jan 9, 2007)8-K (Jan 8, 2007)8-K (Nov 6, 2006)8-K (Oct 18, 2006)8-K (Sep 22, 2006)8-K (Aug 1, 2006)8-K (Jul 27, 2006)8-K (Jul 7, 2006)8-K (Jun 28, 2006)8-K (Jun 9, 2006)8-K (May 31, 2006)8-K (May 12, 2006)8-K (Apr 26, 2006)8-K (Apr 20, 2006)8-K (Apr 18, 2006)8-K (Apr 12, 2006)8-K (Apr 7, 2006)8-K (Mar 31, 2006)8-K (Mar 20, 2006)8-K (Mar 17, 2006)8-K (Mar 8, 2006)8-K (Mar 3, 2006)8-K (Feb 7, 2006)8-K (Jan 27, 2006)8-K (Jan 25, 2006)8-K (Jan 17, 2006)8-K (Jan 13, 2006)8-K (Jan 10, 2006)8-K (Dec 16, 2005)8-K (Dec 5, 2005)8-K (Nov 17, 2005)8-K (Nov 15, 2005)8-K (Oct 28, 2005)8-K (Oct 14, 2005)8-K (Sep 23, 2005)8-K (Aug 15, 2005)8-K (Jul 19, 2005)8-K (Jul 7, 2005)8-K (Jul 5, 2005)8-K (Jun 29, 2005)8-K (Jun 24, 2005)8-K (Jun 3, 2005)8-K (May 13, 2005)8-K (May 4, 2005)8-K (Apr 19, 2005)8-K (Apr 1, 2005)8-K (Feb 1, 2005)8-K (Jan 10, 2005)8-K (Dec 29, 2004)8-K (Dec 20, 2004)8-K (Dec 10, 2004)8-K (Nov 24, 2004)8-K (Nov 18, 2004)8-K (Nov 15, 2004)8-K (Oct 19, 2004)8-K (Sep 30, 2004)8-K (Aug 6, 2004)8-K (Jul 26, 2004)8-K (Jun 25, 2004)8-K (Jun 22, 2004)8-K (Jun 4, 2004)8-K (Jun 1, 2004)8-K (Apr 20, 2004)8-K (Mar 9, 2004)8-K (Feb 2, 2004)8-K (Jan 13, 2004)8-K (Oct 21, 2003)8-K (Sep 16, 2003)8-K (Jul 22, 2003)8-K (Jul 3, 2003)8-K (Apr 21, 2003)8-K (Aug 9, 2002)8-K (May 1, 2001)8-K (Feb 22, 2001)8-K (Jul 1, 1999)8-K (Jun 28, 1999)8-K (Mar 31, 1999)8-K (Nov 24, 1998)8-K (Sep 25, 1998)8-K (Sep 10, 1998)8-K (Jun 18, 1998)8-K (Mar 31, 1998)8-K (Feb 5, 1997)8-K (Jun 17, 1996)8-K (May 16, 1996)

Other

Boston Scientific 8-K 2007

Documents found in this filing:

WWW.EXFILE.COM, INC. -- 14991 -- BOSTON SCIENTIFIC CORP. -- FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 1, 2007

BOSTON SCIENTIFIC CORPORATION

(Exact name of registrant as specified in charter)

DELAWARE	1-11083	04-2695240
(State or other	(Commission	(IRS employer
jurisdiction of	file number)	identification no.)
incorporation)

One Boston Scientific Place, Natick, Massachusetts	01760-1537
(Address of principal executive offices)	(Zip code)

Registrant’s telephone number, including area code: (508) 650-8000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 7.01.

REGULATION FD DISCLOSURE.

On March 5, 2007, Boston Scientific Corporation (the “Company”) issued a press release announcing a request for information received on March 1, 2007, from Representative Henry A. Waxman, Chairman of the Committee on Oversight and Government Reform of the U.S. House of Representatives, about the Company’s TAXUS^® paclitaxel-eluting coronary stents. A copy of the press release is furnished with this report as Exhibit 99.1. A form of the request letter is furnished with this report as Exhibit 99.2.

The information in this Current Report on Form 8-K and the Exhibits attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

ITEM 9.01.

FINANCIAL STATEMENTS AND EXHIBITS.

Exhibit No.

Description

99.1	Press Release issued by Boston Scientific Corporation dated March 5, 2007.

99.2	Form of Letter from the Committee on Oversight and Government Reform dated February 28, 2007.

-2-

SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	BOSTON SCIENTIFIC CORPORATION

Date: March 6, 2007	By:	/s/ Lawrence J. Knopf
		Lawrence J. Knopf
		Vice President and Assistant General Counsel

-3-

INDEX TO EXHIBITS

Exhibit No.

Description

99.1	Press Release issued by Boston Scientific Corporation dated March 5, 2007.

99.2	Form of Letter from the Committee on Oversight and Government Reform dated February 28, 2007.

-4-

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Boston Scientific (BSX)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing: